Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $39,170 - $45,883
-662 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $11,927 - $13,414
201 Added 43.6%
662 $42,000
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $26,618 - $30,163
461 New
461 $29,000
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $26,475 - $29,338
-461 Closed
0 $0
Q1 2020

May 19, 2020

BUY
$46.4 - $67.43 $21,390 - $31,085
461 New
461 $27,000
Q1 2019

Apr 30, 2019

SELL
$45.12 - $53.8 $20,800 - $24,801
-461 Closed
0 $0
Q3 2017

Oct 30, 2017

BUY
$55.23 - $63.74 $25,461 - $29,384
461
461 $29,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Perennial Advisors, LLC Portfolio

Follow Perennial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perennial Advisors, LLC with notifications on news.